|
CELF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.9186874311572E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.15690013124947E-10 |
| Normal-vs-Stage2 |
6.06410000000279E-05 |
| Normal-vs-Stage3 |
1.08235642670707E-12 |
| Normal-vs-Stage4 |
5.10140041320994E-10 |
| Stage1-vs-Stage2 |
2.745000E-01 |
| Stage1-vs-Stage3 |
5.850300E-02 |
| Stage1-vs-Stage4 |
1.745210E-01 |
| Stage2-vs-Stage3 |
1.798020E-02 |
| Stage2-vs-Stage4 |
3.832500E-02 |
| Stage3-vs-Stage4 |
9.362600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.83582055007992E-13 |
| Normal-vs-AfricanAmerican |
8.959600E-04 |
| Normal-vs-Asian |
8.55659999521308E-08 |
| Caucasian-vs-AfricanAmerican |
1.954610E-01 |
| Caucasian-vs-Asian |
9.234800E-01 |
| AfricanAmerican-vs-Asian |
2.611800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.63753513158372E-12 |
| Normal-vs-Female |
8.17934608932092E-12 |
| Male-vs-Female |
2.799600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.85320006404777E-10 |
| Normal-vs-Age(41-60Yrs) |
4.91729990059753E-10 |
| Normal-vs-Age(61-80Yrs) |
5.73874281428743E-12 |
| Normal-vs-Age(81-100Yrs) |
1.420850E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.329400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.506800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.112400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.843800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.886600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.386800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.634880E-04 |
| Classical-VS-Follicular |
7.443000E-01 |
| Classical-VS-Other |
3.613000E-01 |
| Classical-VS-Normal |
2.91420221287808E-11 |
| Tall-VS-Follicular |
5.143700E-03 |
| Tall-VS-Other |
4.627800E-01 |
| Tall-VS-Normal |
2.47535325570425E-12 |
| Follicular-VS-Other |
5.287200E-01 |
| Follicular-VS-Normal |
3.18450000036385E-07 |
| Other-VS-Normal |
2.178600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.76140279718152E-11 |
| Normal-vs-N1 |
1.5296997002423E-10 |
| N0-vs-N1 |
7.854400E-02 |
|
|
